Company Quick10K Filing
Stoke Therapeutics
10-K 2020-12-31 Filed 2021-03-09
10-Q 2020-09-30 Filed 2020-11-12
10-Q 2020-06-30 Filed 2020-08-10
10-Q 2020-03-31 Filed 2020-05-15
10-K 2019-12-31 Filed 2020-03-23
10-Q 2019-09-30 Filed 2019-11-12
10-Q 2019-06-30 Filed 2019-08-14
S-1 2019-05-23 Public Filing
8-K 2020-11-19
8-K 2020-11-12
8-K 2020-10-07
8-K 2020-08-17
8-K 2020-08-13
8-K 2020-08-10
8-K 2020-07-09
8-K 2020-06-03
8-K 2020-05-15
8-K 2020-05-12
8-K 2020-04-14
8-K 2020-03-23
8-K 2020-01-13
8-K 2019-12-07
8-K 2019-11-12
8-K 2019-08-14

Stoke Therapeutics Financials

STOK Metrics, Comps, Filings

Quarterly | Annual

Valuation ($MM)

Market Cap, Enterprise Value

Balance Sheet ($MM)

Assets, Equity

Income Statement ($MM Quarterly)

Revenue, G Profit, Net Income

Cash Flow ($MM Quarterly)

Ops, Inv, Fin

Comps ($'000 TTM) Market Cap Gross Margin EV/EBITDA Ret on Assets Assets Liabilities Revenue G Profit Net Income EBITDA EV
024 Pharma (EEIG)
11 Good Energy (ELVN)
1347 Capital Corp (TFSC)
CNB Financial (CCNE) 450,404 5.1 1% 3,541,170 3,244,137 0 0 38,542 77,627 398,243
1PM Industries (OPMZ)
1st Century Bancshares (FCTY)
1st Financial Services Corp (FFIS)
Timberline Resources (TLR)
Almost Never Films (HLWD)
1st United Bancorp (FUBC)
Manchester United (MANU) 0% 1,496,525 0 0 0 0 -307,637
SQL Technologies (SQFL) 18% 1.5 0% 6,991 29,884 9,299 1,628 0 1,813 2,696
2-Track Global (TTG)
GB Sciences (GBLX) 22,981 -23% -1.8 -56% 29,840 15,525 3,909 -891 -16,597 -12,951 23,417
Nemaura Medical (NMRD) 158,102 -32.0 -182% 2,704 2,507 0 0 -4,919 -4,879 156,331
Monroe Bank and Trust (MBTF) 231,777 -6.6 1% 1,326,547 1,191,110 0 0 10,048 16,197 -106,841
Solis Tek (SLTK) 43,678 51% -25.8 -163% 1,378 6,785 1,895 973 -2,244 -1,693 43,612
Cumulus Media (CMLS) -94.7 -0% 0 0 0 -10,600 1,003,622
Cyclo Therapeutics, Inc. (CYTHW)
ALABAMA POWER CO (APRCP)

Balance Sheet ($'000)2019-06-302019-09-30
Cash242,885233,254
Accounts Receivable
Inventory
PP&E1,7221,942
Assets246,372238,827
Accounts Payable1,2381,789
Long-Term Debt
Liabilities4,8365,144
Stockholders' Equity241,536233,683
Income Statement ($'000)2019-06-302019-09-30
Revenue
Cost of Revenue
Gross Profit
R&D6,0236,518
SG&A2,4223,324
Tax00
Net Income-7,819-8,604
Cash Flow ($'000)2019-06-302019-09-30
Cash Operating-8,048
Cash Investing-583
Cash Financing-1,000